Global Transdermal Drug Delivery System Market

Global Transdermal Drug Delivery System Market Research Report 2021

Global Transdermal Drug Delivery System Market

Global Transdermal Drug Delivery System Market Research Report 2021


Insights into the Transdermal Drug Delivery System Market include supply chain optimization, Transdermal Drug Delivery System challenges, and growth forecasts segmented by region and service type.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Research Predicts that Transdermal Drug Delivery System Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.

Global Transdermal Drug Delivery System Market Overview:

Global Transdermal Drug Delivery System Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Transdermal Drug Delivery System involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

Impact of COVID-19 on Transdermal Drug Delivery System Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Transdermal Drug Delivery System market in 2020.

Global Transdermal Drug Delivery System Market Segmentation

By Type, Transdermal Drug Delivery System market has been segmented into:

Fentanyl

Nitroglycerin

Estradiol

Nicotine

Others

By Application, Transdermal Drug Delivery System market has been segmented into:

OTC

Rx

Regional Analysis:

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Top Key Players Covered in Transdermal Drug Delivery System market are:

Hisamitsu

Mylan

GSK

Novartis

Teve (Actavis)

Johnson & Johnson

Lohmann

Teikoku Seiyaku

Bayer

Lingrui

Sanofi

Qizheng

Endo

Huarun 999

Haw Par

Nichiban

Mentholatum Company

Laboratoires Genevrier

1. Market Overview of Transdermal Drug Delivery System

1.1 Transdermal Drug Delivery System Market Overview

1.1.1 Transdermal Drug Delivery System Product Scope

1.1.2 Market Status and Outlook

1.2 Transdermal Drug Delivery System Market Size by Regions: 2015 VS 2021 VS 2026

1.3 Transdermal Drug Delivery System Historic Market Size by Regions (2015-2020)

1.4 Transdermal Drug Delivery System Forecasted Market Size by Regions (2021-2026)

1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)

1.5.1 North America

1.5.2 East Asia

1.5.3 Europe

1.5.4 South Asia

1.5.5 Southeast Asia

1.5.6 Middle East

1.5.7 Africa

1.5.8 Oceania

1.5.9 South America

1.5.10 Rest of the World

1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.6.2 Covid-19 Impact: Commodity Prices Indices

1.6.3 Covid-19 Impact: Global Major Government Policy

2. Covid-19 Impact Transdermal Drug Delivery System Sales Market by Type (2015-2026)

2.1 Global Transdermal Drug Delivery System Historic Market Size by Type (2015-2020)

2.2 Global Transdermal Drug Delivery System Forecasted Market Size by Type (2021-2026)

2.3 Fentanyl

2.4 Nitroglycerin

2.5 Estradiol

2.6 Nicotine

2.7 Others

3. Covid-19 Impact Transdermal Drug Delivery System Sales Market by Application (2015-2026)

3.1 Global Transdermal Drug Delivery System Historic Market Size by Application (2015-2020)

3.2 Global Transdermal Drug Delivery System Forecasted Market Size by Application (2021-2026)

3.3 OTC

3.4 Rx

4. Covid-19 Impact Market Competition by Manufacturers

4.1 Global Transdermal Drug Delivery System Production Capacity Market Share by Manufacturers (2015-2020)

4.2 Global Transdermal Drug Delivery System Revenue Market Share by Manufacturers (2015-2020)

4.3 Global Transdermal Drug Delivery System Average Price by Manufacturers (2015-2020)

5. Company Profiles and Key Figures in Transdermal Drug Delivery System Business

5.1 Hisamitsu

5.1.1 Hisamitsu Company Profile

5.1.2 Hisamitsu Transdermal Drug Delivery System Product Specification

5.1.3 Hisamitsu Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.2 Mylan

5.2.1 Mylan Company Profile

5.2.2 Mylan Transdermal Drug Delivery System Product Specification

5.2.3 Mylan Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.3 GSK

5.3.1 GSK Company Profile

5.3.2 GSK Transdermal Drug Delivery System Product Specification

5.3.3 GSK Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.4 Novartis

5.4.1 Novartis Company Profile

5.4.2 Novartis Transdermal Drug Delivery System Product Specification

5.4.3 Novartis Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.5 Teve (Actavis)

5.5.1 Teve (Actavis) Company Profile

5.5.2 Teve (Actavis) Transdermal Drug Delivery System Product Specification

5.5.3 Teve (Actavis) Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.6 Johnson & Johnson

5.6.1 Johnson & Johnson Company Profile

5.6.2 Johnson & Johnson Transdermal Drug Delivery System Product Specification

5.6.3 Johnson & Johnson Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.7 Lohmann

5.7.1 Lohmann Company Profile

5.7.2 Lohmann Transdermal Drug Delivery System Product Specification

5.7.3 Lohmann Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.8 Teikoku Seiyaku

5.8.1 Teikoku Seiyaku Company Profile

5.8.2 Teikoku Seiyaku Transdermal Drug Delivery System Product Specification

5.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.9 Bayer

5.9.1 Bayer Company Profile

5.9.2 Bayer Transdermal Drug Delivery System Product Specification

5.9.3 Bayer Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.10 Lingrui

5.10.1 Lingrui Company Profile

5.10.2 Lingrui Transdermal Drug Delivery System Product Specification

5.10.3 Lingrui Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.11 Sanofi

5.11.1 Sanofi Company Profile

5.11.2 Sanofi Transdermal Drug Delivery System Product Specification

5.11.3 Sanofi Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.12 Qizheng

5.12.1 Qizheng Company Profile

5.12.2 Qizheng Transdermal Drug Delivery System Product Specification

5.12.3 Qizheng Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.13 Endo

5.13.1 Endo Company Profile

5.13.2 Endo Transdermal Drug Delivery System Product Specification

5.13.3 Endo Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.14 Huarun 999

5.14.1 Huarun 999 Company Profile

5.14.2 Huarun 999 Transdermal Drug Delivery System Product Specification

5.14.3 Huarun 999 Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.15 Haw Par

5.15.1 Haw Par Company Profile

5.15.2 Haw Par Transdermal Drug Delivery System Product Specification

5.15.3 Haw Par Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.16 Nichiban

5.16.1 Nichiban Company Profile

5.16.2 Nichiban Transdermal Drug Delivery System Product Specification

5.16.3 Nichiban Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.17 Mentholatum Company

5.17.1 Mentholatum Company Company Profile

5.17.2 Mentholatum Company Transdermal Drug Delivery System Product Specification

5.17.3 Mentholatum Company Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.18 Laboratoires Genevrier

5.18.1 Laboratoires Genevrier Company Profile

5.18.2 Laboratoires Genevrier Transdermal Drug Delivery System Product Specification

5.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

6. North America

6.1 North America Transdermal Drug Delivery System Market Size (2015-2026)

6.2 North America Transdermal Drug Delivery System Key Players in North America (2015-2020)

6.3 North America Transdermal Drug Delivery System Market Size by Type (2015-2020)

6.4 North America Transdermal Drug Delivery System Market Size by Application (2015-2020)

7. East Asia

7.1 East Asia Transdermal Drug Delivery System Market Size (2015-2026)

7.2 East Asia Transdermal Drug Delivery System Key Players in North America (2015-2020)

7.3 East Asia Transdermal Drug Delivery System Market Size by Type (2015-2020)

7.4 East Asia Transdermal Drug Delivery System Market Size by Application (2015-2020)

8. Europe

8.1 Europe Transdermal Drug Delivery System Market Size (2015-2026)

8.2 Europe Transdermal Drug Delivery System Key Players in North America (2015-2020)

8.3 Europe Transdermal Drug Delivery System Market Size by Type (2015-2020)

8.4 Europe Transdermal Drug Delivery System Market Size by Application (2015-2020)

9. South Asia

9.1 South Asia Transdermal Drug Delivery System Market Size (2015-2026)

9.2 South Asia Transdermal Drug Delivery System Key Players in North America (2015-2020)

9.3 South Asia Transdermal Drug Delivery System Market Size by Type (2015-2020)

9.4 South Asia Transdermal Drug Delivery System Market Size by Application (2015-2020)

10. Southeast Asia

10.1 Southeast Asia Transdermal Drug Delivery System Market Size (2015-2026)

10.2 Southeast Asia Transdermal Drug Delivery System Key Players in North America (2015-2020)

10.3 Southeast Asia Transdermal Drug Delivery System Market Size by Type (2015-2020)

10.4 Southeast Asia Transdermal Drug Delivery System Market Size by Application (2015-2020)

11. Middle East

11.1 Middle East Transdermal Drug Delivery System Market Size (2015-2026)

11.2 Middle East Transdermal Drug Delivery System Key Players in North America (2015-2020)

11.3 Middle East Transdermal Drug Delivery System Market Size by Type (2015-2020)

11.4 Middle East Transdermal Drug Delivery System Market Size by Application (2015-2020)

12. Africa

12.1 Africa Transdermal Drug Delivery System Market Size (2015-2026)

12.2 Africa Transdermal Drug Delivery System Key Players in North America (2015-2020)

12.3 Africa Transdermal Drug Delivery System Market Size by Type (2015-2020)

12.4 Africa Transdermal Drug Delivery System Market Size by Application (2015-2020)

13. Oceania

13.1 Oceania Transdermal Drug Delivery System Market Size (2015-2026)

13.2 Oceania Transdermal Drug Delivery System Key Players in North America (2015-2020)

13.3 Oceania Transdermal Drug Delivery System Market Size by Type (2015-2020)

13.4 Oceania Transdermal Drug Delivery System Market Size by Application (2015-2020)

14. South America

14.1 South America Transdermal Drug Delivery System Market Size (2015-2026)

14.2 South America Transdermal Drug Delivery System Key Players in North America (2015-2020)

14.3 South America Transdermal Drug Delivery System Market Size by Type (2015-2020)

14.4 South America Transdermal Drug Delivery System Market Size by Application (2015-2020)

15. Rest of the World

15.1 Rest of the World Transdermal Drug Delivery System Market Size (2015-2026)

15.2 Rest of the World Transdermal Drug Delivery System Key Players in North America (2015-2020)

15.3 Rest of the World Transdermal Drug Delivery System Market Size by Type (2015-2020)

15.4 Rest of the World Transdermal Drug Delivery System Market Size by Application (2015-2020)

16 Transdermal Drug Delivery System Market Dynamics

16.1 Covid-19 Impact Market Top Trends

16.2 Covid-19 Impact Market Drivers

16.3 Covid-19 Impact Market Challenges

16.4 Porter’s Five Forces Analysis

18 Regulatory Information

17 Analyst's Viewpoints/Conclusions

18 Appendix

18.1 Research Methodology

18.1.1 Methodology/Research Approach

18.1.2 Data Source

18.2 Disclaimer

Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Transdermal Drug Delivery System Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Who are the dominant players having a strong presence in the Transdermal Drug Delivery System Market?
Some of the finest and top-notch companies pioneering the Transdermal Drug Delivery System Market are Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku, Bayer, Lingrui, Sanofi, Qizheng, Endo, Huarun 999, Haw Par, Nichiban, Mentholatum Company, Laboratoires Genevrier.
What trends are influencing the growth of the Transdermal Drug Delivery System Market?
New players are entering the Transdermal Drug Delivery System Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
Who are the significant end-users in the Transdermal Drug Delivery System Market?
The key end-users in the Transdermal Drug Delivery System Market are OTC, Rx
What is the forecasted growth rate of the Transdermal Drug Delivery System Market?
The Transdermal Drug Delivery System Market is expected to grow at a moderate CAGR during the forecast period of 2025 to 2030.
What are the underlying opportunities in the Transdermal Drug Delivery System Market?
The influx of capital into the Transdermal Drug Delivery System Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
What are the top priorities for the growth of the Transdermal Drug Delivery System Market?
In this highly competitive and rapidly evolving Transdermal Drug Delivery System Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.